Hebrew University of Jerusalem

NCT07759895

Collaborator, Phase 2, Recruiting, 2026, 80 people, 12 Aug 2026, clinicaltrials.gov

NCT06078891

Collaborator, Early phase 1, Enrolling by invitation, 2023, 60 people, 12 Oct 2023, clinicaltrials.gov

NCT03078309

Collaborator, Early phase 1, Status unknown, 2018, 50 people, 13 Mar 2017, clinicaltrials.gov

European Commission

HORIZON-IA, OPTIMISING THE MANUFACTURING PLATFORM FOR INDIVIDUALIZED IPS CELL BASED HEART REPAIR, 101288899, €1m, 2026–2030, 18 May 2026, cordis.europa.eu

European Research Council

HORIZON-ERC-POC, Somatostatin Receptor Inhibitors for Sustaining Muscle and Bone Mass Following Pharmacologically Induced Weight Loss, 101202828, €150k, 2025–2026, 14 Feb 2025, cordis.europa.eu

Dementia progression with GLP-1 receptor agonists in people with mild cognitive impairment and type 2 diabetes: target-trial emulation study

Employment, 20 Sept 2026, pubmed.ncbi.nlm.nih.gov